Literature DB >> 31689572

Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.

Kenn Forberg1, Mary A Rodgers1, George J Dawson1, Silvia Sauleda2, Ana Olivo1, Ana Vallari1, Marta Bes2, Maria Piron2, Gavin A Cloherty1, Michael G Berg3.   

Abstract

We applied an NGS based target capture approach to amplify HPgV-2 sequences from metagenomic libraries and enable full genome characterization. Despite expanded geographical sampling, sequence variability remains low, with diversity concentrated in approximately 3.3% of all amino acids. Serial samples from one HPgV-2 positive individual co-infected with comparable titers of HIV, HCV, and GBV-C showed that HPgV-2 remains highly stable over several weeks compared to other RNA viruses, despite a similarly error-prone polymerase. The consistent epidemiological association with and structural similarities to HCV, and the weak positive correlation of HCV and HPgV-2 titers shown here, suggests it may benefit from co-infection. While minimal selective pressure on HPgV-2 to evolve could suggest fitness, the rarity of HPgV-2 and the tight phylogenetic clustering of global strains likely indicates origination from a common source and a virus that is ill-suited to its host. Sporadic infections may explain the limited genetic diversity observed worldwide.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis C virus; Next-generation sequencing; Pegivirus; Viral diversity; xGen target enrichment

Mesh:

Substances:

Year:  2019        PMID: 31689572     DOI: 10.1016/j.virol.2019.10.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

Review 1.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

2.  Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication.

Authors:  Zhengwei Wan; Junwei Liu; Fengyu Hu; Jingwei Shui; Linghua Li; Haiying Wang; Xiaoping Tang; Chengguang Hu; Yuanhao Liang; Yuanping Zhou; Weiping Cai; Shixing Tang
Journal:  Emerg Microbes Infect       Date:  2020-02-26       Impact factor: 7.163

Review 3.  Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Authors:  Mehdi Samadi; Vahid Salimi; Mohammad Reza Haghshenas; Seyed Mohammad Miri; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Virol J       Date:  2022-03-09       Impact factor: 4.099

Review 4.  The Second Human Pegivirus, a Non-Pathogenic RNA Virus with Low Prevalence and Minimal Genetic Diversity.

Authors:  Shuyi Chen; Haiying Wang; Emmanuel Enoch Dzakah; Farooq Rashid; Jufang Wang; Shixing Tang
Journal:  Viruses       Date:  2022-08-23       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.